Back to search
FDAFDA · Food and drugs·Recall number D-0418-2026

Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individual Dose ( NDC 60687-775-11), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio, 43217.

Published April 1, 2026 · Recall initiated: March 16, 2026

Summary

FDA records drug Class II recall D-0418-2026, published April 1, 2026 and initiated March 16, 2026. Recalling firm: Amerisource Health Services LLC; Status: Ongoing; Reported quantity: 697 cartons; Lot: Lot #1024852; Exp 9/30/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed tablet specifications.

What to do

Voluntary: Firm initiated · Letter

Get an email if MECLIZINE HYDROCHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
MECLIZINE HYDROCHLORIDE
Manufacturer
Amerisource Health Services LLC
Distributor
U.S. Nationwide
Lot
Lot #1024852; Exp 9/30/2026
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individual Dose ( NDC 60687-775-11), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio, 43217. recalled?

Yes. FDA published recall D-0418-2026 on April 1, 2026. Reported hazard: Failed tablet specifications.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: MECLIZINE HYDROCHLORIDE.